To healthcare providers, patients and clinicians, what matters most is not necessarily how well a treatment performs under the artificially controlled conditions on a randomised controlled trial (RCT), but the results seen in clinical practice.
Evidence from ‘uncontrolled observational studies‘ provides insight into changes in patients who have received treatment provided by homeopaths. These studies consistently show that patients improve clinically following homeopathic treatment (often from chronic, difficult to treat conditions); some also highlight areas of potential economic benefit for the NHS as a whole in terms of reduced prescribing of conventional drugs.
Four published studies carried out from 1999 to the present day have tracked the outcome of patients being treated at NHS homeopathic hospitals:
An outcome survey carried out at the Liverpool department of homeopathic medicine over a 12 month period in 1999-2000 surveyed 1,100 patients1; 76.6% reported an improvement in their condition since starting homeopathic treatment and 60.3% regarded their improvement as major. 814 patients were taking conventional treatment for their condition and 424 [52%] of these were able to reduce or stop conventional medication.
Bristol Homeopathic Hospital (2005)
An observational study at Bristol Homeopathic Hospital included over 6,500 consecutive patients with over 23,000 attendances in a six-year period;3 70% of follow-up patients reported improved health, 50% major improvement. The largest improvements were reported in childhood eczema or asthma, and in inflammatory bowel disease, irritable bowel syndrome, menopausal problems and migraine.
Bristol, Glasgow, Liverpool, London and Tunbridge Wells (2008)
In this pilot study, data from 1602 follow-up patient appointments at all five NHS homeopathic hospitals were collected together over a one-month period.4 At their second homeopathic appointment, 34% of follow-up patients overall reported an improvement that affected their daily living. For patients at their sixth appointment, the corresponding improvement rate was 59%. Eczema, chronic fatigue syndrome, menopausal disorder, osteoarthritis and depression were the “top five” most referred conditions.
‘EPI3’ Project (2008-2012)
Homeopathy is widely used in France and a major study following 8559 patients attending GP practices was used to assess the effectiveness of homeopathic treatment. This ’EPI3 study’5 is managed by LA-SER a UK-based company specialised in scientific evidence for medicine and health technologies (http://www.la-ser.com/). The project team includes individuals from high-profile institutions such as the Institut Pasteur in Paris, University of Bordeaux and McGill University, Montreal; Lucien Abenhaim is the French General Director of Health (Surgeon General).
Key findings of the EPI3 project:
- Upper respiratory tract infections (URTIs)
Patients treated by GPs trained in homeopathy did as well clinically as those treated with conventional medicine, but used fewer conventional drugs.6
This study investigated the use of antibiotics and antipyretic/anti-inflammatory drugs use for the treatment of upper respiratory tract infections (URTIs). 518 adults and children with URTIs were included. Patients who consulted with GPs certified in homeopathy showed significantly lower consumption of antibiotics (OR=0.43, CI: 0.27–0.68) and antipyretic/anti-inflammatory drugs (OR=0.54, 95% CI: 0.38–0.76), with similar evolution in related symptoms.
- Musculoskeletal disorders (MSDs)
Patients treated with homeopathy did as well clinically as those treated with conventional medicine, but used only half the amount of non-steroidal anti-inflammatory drugs (NSAIDs) and had fewer NSAID-related side effects.7
1153 eligible patients with MSD were followed for 12 months, comparing groups who received homeopathy (N=371) or conventional medicine (CM; N=272), or a mixed approach involving both approaches (N=510). Patients did not differ between groups except for chronicity of MSDs, which was higher in the homeopathy group (62.1%) than in both the CM (48.6%) and mixed (50.3%) groups. The twelve-month development of specific functional scores was identical for all groups (p > 0.05). After adjusting for propensity scores, NSAID use over 12 months was almost half in the homeopathy group (OR, 0.54; 95%CI, 0.38-0.78) as compared to the CM group; no statistically significant difference was found in the mixed group (OR, 0.81; 95% CI: 0.59-1.15). MSD patients seen by homeopathic physicians showed a similar clinical progression when less exposed to NSAID in comparison to patients seen in CM practice, with fewer NSAID-related adverse events and no loss of therapeutic opportunity.
- Sleep, anxiety and depressive disorders (SADD)
Patients treated by certified homeopathic physicians were less likely to be prescribed psychotropic drugs.8
The EPI3 study ‘SADD’ study involved 1572 patients diagnosed with sleep, anxiety and depressive disorders seeking treatment from physicians in general practice (GPs), with three different practice preferences: strictly conventional medicine (GP-CM), mixed complementary and conventional medicine (GP-Mx) and certified homeopathic physicians (GP-Ho). Psychotropic drugs were more likely to be prescribed by GP-CM (64%) than GP-Mx (55.4%) and GP-Ho (31.2%). The three groups of patients shared similar SADD severity in terms of comorbidities and quality of life.
Comparing homeopathy and conventional care (2005)
A study commissioned by a German health insurance company to determine whether to continue covering homeopathic treatment assessed the value of homeopathy in treating chronic conditions commonly seen in general practice.9
493 patients (315 adults, 178 children) treated by general practitioners received either conventional medicine or homeopathy. The study found that patients in the homeopathy group reported greater improvement than the conventional medicine group (p=0.002) with no significant difference in cost.
Eight-year follow up of chronically ill patients treated with homeopathy (2008)
This study which followed over 3500 adults and children receiving routine homeopathic care from GPs,10 found that “patients who seek homeopathic treatment are likely to improve considerably”. At the start, 97% of participants were diagnosed with a chronic complaint, with 95% declaring prior conventional treatment for their condition. Disease severity decreased significantly (p < 0.001) between the start of the study, after 2 years and after 8 years of homeopathic treatment. Notably, after 8 years, figures were almost identical to 2-year follow-up, indicating steady long-term health benefits.
Main outcome measures, utilising conventional medical research instruments, included quality of life (QoL) and numerical severity scale assessments. One in two patients experienced reductions of 50% in symptom severity after 8 years, with corresponding changes in QoL measures. Of adults, almost 50% of responders (67.4% total study population) experienced “clinically relevant treatment success” (complaint severity reduced 2 points or more on a 10-point scale); in children the figure was 80%. Younger age, female gender and more severe disease at baseline were factors predictive of better therapeutic success.
- Richardson W R. Patient benefit survey: Liverpool Regional Department of Homoeopathic Medicine. Br Homeopath J, 2001; 90: 158-162 | PubMed
- Sharples F, van Haselen R, Fisher P. NHS patients’ perspective on complementary medicine. Complement Ther Med, 2003; 11: 243-248 | PubMed
- Spence D, Thompson E A, Barron S J. Homeopathic treatment for chronic disease: a 6-year university-hospital outpatient observational study. J Altern Complement Med, 2005; 5: 793-798 | PubMed
- Thompson E A, Mathie R T, Baitson E S, Barron S J, Berkovitz S R, Brands M, Fisher P, Kirby T M, Leckridge R W, Mercer S W, Nielsen H J, Ratsey D H K, Reilly D, Roniger H, Whitmarsh TE (2008). Towards standard setting for patient-reported outcomes in the NHS homeopathic hospitals. Homeopathy, 2008; 97: 114-121 | PubMed
- Grimaldi-Bensouda, L. et al. Benchmarking the burden of 100 diseases: results of a nationwide representative survey within general practices. BMJ Open, 2011; 1: e000215 | Full text
- Grimaldi-Bensouda, L. et al. Management of upper respiratory tract infections by different medical practices, including homeopathy, and consumption of antibiotics in primary care: the EPI3 cohort study in France 2007-2008. PLoS One, 2014; 9: e89990 | Full text
- Rossignol, M. et al. Impact of physician preferences for homeopathic or conventional medicines on patients with musculoskeletal disorders: results from the EPI3-MSD cohort. Drug Saf., 2012; 21: 1093–1101 | PubMed
- Grimaldi-Bensouda, L. et al. Who seeks primary care for sleep, anxiety and depressive disorders from physicians prescribing homeopathic and other complementary medicine? Results from the EPI3 population survey. BMJ Open, 2012; 2 | Full text
- Witt C, Keil T, Selim D, et al. Outcome and costs of homeopathic and conventional treatmentstrategies: a comparative cohort study in patients with chronic disorders. Complement Ther Med, 2005; 13: 79-86 | PubMed
- Witt, C. M., Lüdtke, R., Mengler, N. & Willich, S. N. How healthy are chronically ill patients after eight years of homeopathic treatment?–Results from a long term observational study. BMC Public Health, 2008; 8: 413 | Full text